E.coli O157 & Haemolytic Uraemic Syndrome

The Mail Online suggests new hope in treatment of Shiga toxin-producing Escherichia coli (STEC) Haemolytic Uraemic Syndrome (HUS)

23rd October 2023

According to the Mail Online article, link below, of 21st October 2023, there appears to be hope in relation to the treatment of STEC caused HUS.

We are currently trying to find out more information on this latest news about the proposed treatment and possible trial of Eculizumab, also known as Soliris.

There was a previous trial using this drug, unfortunately the trial was cancelled during the Covid-19 pandemic in 2020.

We have to treat this news cautiously until we know more, but do hope a suitable treatment such as this, can be found for STEC HUS cases as there is no specific treatment at the present time for this devastating illness.

To date, efforts to prevent these types of bacterium entering the food chain or the environment, have not, worked significantly well enough to reduce the number of human cases.

Obviously, in an ideal world, prevention would be better than cure.

1 of 47
Next > Last >>

21st June 2024

According to an update yesterday the 20th June 2024 from the  UK Health Security Agency (UKHSA) ,the number of confirmed ... on
14th June 2024

Two suppliers of Supermarket sandwiches and wraps recall products as a precaution after E.coli O145 (Shiga toxin-producing Escherichia coli often referred to as ... on
6th June 2024

The UK Health Security Agency (UKHSA) has advised of a large outbreak of Shiga toxin-producing Escherichia coli (STEC) O145, that currently appears to be spreading across the UK. This follow... on
19th April 2024

The UK Health Security Agency (UKHSA) data released yesterday 18/04/2024 for 2021 shows Shiga toxin-producing Escherichia coli (STEC) ... on
11th March 2024

According to an Article in the Guardian newspaper on Wednesday 6th March 2024 people in England are facing food poisoning ‘Russian roulette’ as... on
1 of 47
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy